Amica Retiree Medical Trust’s Helen of Troy HELE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,797
Closed -$410K 104
2021
Q2
$410K Hold
1,797
0.26% 93
2021
Q1
$379K Hold
1,797
0.26% 97
2020
Q4
$399K Hold
1,797
0.28% 97
2020
Q3
$348K Hold
1,797
0.27% 103
2020
Q2
$339K Hold
1,797
0.27% 113
2020
Q1
$259K Hold
1,797
0.23% 133
2019
Q4
$323K Hold
1,797
0.25% 111
2019
Q3
$283K Buy
1,797
+334
+23% +$49.6K 0.23% 131
2019
Q2
$191K Hold
1,463
0.16% 182
2019
Q1
$170K Hold
1,463
0.15% 197
2018
Q4
$192K Sell
1,463
-1,381
-49% -$181K 0.18% 161
2018
Q3
$372K Hold
2,844
0.31% 102
2018
Q2
$280K Hold
2,844
0.24% 119
2018
Q1
$247K Hold
2,844
0.22% 144
2017
Q4
$274K Hold
2,844
0.21% 143
2017
Q3
$276K Buy
2,844
+263
+10% +$25.3K 0.22% 136
2017
Q2
$243K Buy
+2,581
New +$240K 0.2% 148

Other funds holding HELE

Amica Retiree Medical Trust's HELE Position: Q3 2021 in Review

Amica Retiree Medical Trust sold out of Helen of Troy (HELE) in Q3 2021, closing a stake of 1,797 shares — an estimated $410K sold.

Amica Retiree Medical Trust first reported a position in HELE in Q2 2017 and held it in 17 quarters. The position peaked at $410K in Q2 2021. 280 funds tracked by Wall St. Rank hold HELE as of Q3 2021.

  • Amica Retiree Medical Trust reported no remaining Helen of Troy position as of Q3 2021 after selling out during the quarter.
  • Amica Retiree Medical Trust sold 1,797 Helen of Troy shares in Q3 2021, an estimated $410K.
  • Amica Retiree Medical Trust first reported a position in Helen of Troy in Q2 2017 and held it in 17 quarters.
  • Amica Retiree Medical Trust's Helen of Troy position peaked at $410K in Q2 2021.
  • 280 funds tracked by Wall St. Rank held Helen of Troy as of Q3 2021.

Based on Amica Retiree Medical Trust's 13F filing for Q3 2021, filed 3 Nov 2021.